AAM
HAE icon

Arabesque Asset Management’s Haemonetics HAE Stock Holding History

Arabesque Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-22,808
Closed -$2.62M – 79
2019
Q4 		$2.62M Buy
22,808
+5,835
+34% +$706K 1.01% 42
2019
Q3 		$2.14M Buy
16,973
+305
+2% +$38.7K 0.99% 49
2019
Q2 		$2.01M Sell
16,668
-1,928
-10% -$190K 0.92% 51
2019
Q1 		$1.63M Buy
18,596
+1,196
+7% +$109K 0.84% 55
2018
Q4 		$1.74M Buy
+17,400
New +$1.83M 1.71% 25

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Arabesque Asset Management's HAE Position: Q1 2020 in Review

Arabesque Asset Management sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 22,808 shares — an estimated $2.62M sold.

Arabesque Asset Management first reported a position in HAE in Q4 2018 and held it in 5 quarters. The position peaked at $2.62M in Q4 2019. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • Arabesque Asset Management reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • Arabesque Asset Management sold 22,808 Haemonetics shares in Q1 2020, an estimated $2.62M.
  • Arabesque Asset Management first reported a position in Haemonetics in Q4 2018 and held it in 5 quarters.
  • Arabesque Asset Management's Haemonetics position peaked at $2.62M in Q4 2019.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on Arabesque Asset Management's 13F filing for Q1 2020, filed 17 Apr 2020.